3.財務諸表及び主な注記

(1)貸借対照表

 

 

(単位:千円)

 

前事業年度

(2025年3月31日)

当事業年度

(2026年3月31日)

資産の部

 

 

流動資産

 

 

現金及び預金

1,667,921

1,515,346

売掛金

22,214

18,123

製品

1,539

1,719

仕掛品

2,142

貯蔵品

3,774

3,257

前渡金

3,104

4,630

前払費用

11,474

8,864

未収消費税等

50,299

34,092

その他

15,646

20,682

流動資産合計

1,775,974

1,608,859

固定資産

 

 

有形固定資産

 

 

建物

1,281

1,281

減価償却累計額

1,281

1,281

建物(純額)

0

0

工具、器具及び備品

89,397

89,765

減価償却累計額

89,397

89,764

工具、器具及び備品(純額)

0

0

有形固定資産合計

0

0

無形固定資産

 

 

その他

0

0

無形固定資産合計

0

0

投資その他の資産

 

 

差入保証金

42,862

14,681

投資その他の資産合計

42,862

14,681

固定資産合計

42,862

14,682

資産合計

1,818,837

1,623,541

 

 

 

 

(単位:千円)

 

前事業年度

(2025年3月31日)

当事業年度

(2026年3月31日)

負債の部

 

 

流動負債

 

 

未払金

61,012

25,904

未払費用

41,607

32,671

未払法人税等

18,273

1,927

預り金

3,973

4,939

流動負債合計

124,866

65,441

固定負債

 

 

長期預り金

261,564

340,330

固定負債合計

261,564

340,330

負債合計

386,431

405,771

純資産の部

 

 

株主資本

 

 

資本金

2,437,908

751,161

資本剰余金

 

 

資本準備金

2,723,798

1,104,366

資本剰余金合計

2,723,798

1,104,366

利益剰余金

 

 

その他利益剰余金

 

 

繰越利益剰余金

3,808,501

718,108

利益剰余金合計

3,808,501

718,108

自己株式

21

30

株主資本合計

1,353,183

1,137,388

新株予約権

79,223

80,381

純資産合計

1,432,406

1,217,770

負債純資産合計

1,818,837

1,623,541

 

E3551048820株式会社ペルセウスプロテオミクスPerseus Proteomics Inc.通期第2号参考様式 [日本基準](非連結)Japan GAAPfalseCTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse488202024-04-012025-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalStockMember488202026-05-14488202025-04-012026-03-31488202026-03-31jppfs_cor:TreasuryStockMemberjppfs_cor:NonConsolidatedMember488202025-04-012026-03-31jppfs_cor:TreasuryStockMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember488202024-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember488202024-04-012025-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember488202026-03-31jppfs_cor:NonConsolidatedMember488202025-04-012026-03-31jppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:NonConsolidatedMember488202026-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202026-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202026-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202026-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202026-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202026-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:LegalCapitalSurplusMember488202026-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalStockMember488202025-04-012026-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:SubscriptionRightsToSharesMember488202025-04-012026-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:ShareholdersEquityMember488202025-04-012026-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202025-04-012026-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202025-04-012026-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202025-04-012026-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202025-04-012026-03-31jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsMember488202024-04-012025-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202026-03-31jppfs_cor:OtherCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202025-04-012026-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:OtherCapitalSurplusMember488202025-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:OtherCapitalSurplusMemberxbrli:pureiso4217:JPY